article thumbnail

HOST-BR: Optimal DAPT Duration in Patients With High and Low Bleeding Risk?

American College of Cardiology

After stent implantation, a three-month regimen of dual antiplatelet therapy (DAPT) was more effective than a one-month regimen at reducing adverse events without increasing bleeding risk in patients with a high bleeding risk (HBR), according to a Late-Breaking Clinical Trial presented at ACC.25 25 in Chicago.

Stent 72
article thumbnail

Transcatheter Covered Stent Exclusion of Sinus Venosus Defects

American College of Cardiology

What are the outcomes of transcatheter occlusion of sinus venosus defects (SVD) with covered stent?

Stent 61
article thumbnail

Long-term management of recurrent in-stent restenosis

Cardiology Update

A recent study published in JACC: Cardiovascular Interventions has provided new insights into the long-term management of patients suffering from recurrent in-stent restenosis (ISR), a condition presenting notable challenges in cardiovascular treatment. Original article: Koch T et al. The median follow-up period was 10.3

Stent 52
article thumbnail

FLASH: AI-Based Quantitative Angiography Shows Promise For Assisting PCI

American College of Cardiology

Results from the FLASH trial demonstrate the noninferiority of artificial intelligence-based fully automated quantitative coronary angiography (AI-QCA)-assisted PCI compared with optical coherence tomography (OCT)-guided PCI in achieving optimal minimal stent area, with comparable procedural complications, OCT-defined endpoints, and six-month clinical (..)

Stent 53
article thumbnail

Drug-eluting stents for coronary artery disease in the perspective of bibliometric analysis

Frontiers in Cardiovascular Medicine

Drug-eluting stents (DES) play a crucial role in treating coronary artery disease (CAD) by preventing restenosis. These stents are coated with drug carriers that release antiproliferative drugs within the vessel. Out of 5,778 articles, we meticulously screened them based on predefined inclusion and exclusion criteria.

article thumbnail

Drug-Coated Balloon Angioplasty With Rescue Stenting Versus Intended Stenting for the Treatment of Patients With de Novo Coronary Artery Lesions

American College of Cardiology

The goal of the REC-CAGEFREE I trial was to assess the safety and efficacy of a paclitaxel-coated balloon (DCB) compared to drug-eluting stent (DES) implantation among patients with coronary in-stent restenosis.

Stent 49
article thumbnail

Do You Need A Stent To Treat Your Heart Disease?

Dr. Paddy Barrett

One of the most common questions I get is, “ Do I need a stent to treat my heart disease?” ” Typically, several of this person’s friends have had stents, so it seems natural to ask. First, we must understand what a stent is and why it is used. The stent ‘unblocks’ it. Flow is restored.

Stent 52